Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 14, 2023

BUY
$21.38 - $29.19 $42 - $58
2 Added 0.13%
1,532 $43,000
Q1 2023

Apr 28, 2023

SELL
$21.74 - $30.93 $43 - $61
-2 Reduced 0.13%
1,530 $35,000
Q4 2022

Jan 13, 2023

BUY
$24.81 - $31.52 $49 - $63
2 Added 0.13%
1,532 $0
Q4 2020

Feb 04, 2021

BUY
$33.21 - $46.54 $21,586 - $30,251
650 Added 73.86%
1,530 $66,000
Q1 2020

May 14, 2020

BUY
$31.52 - $53.81 $27,737 - $47,352
880 New
880 $31,000

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.24B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.